Literature DB >> 8680497

Managing agitation in critically ill patients.

M A Harvey1.   

Abstract

Managing agitation in critically ill patients is challenging and complex. Advances in the field of critical care impose strains on patients that can lead to disorientation and agitation, especially as more severe illnesses are treated successfully. Although the adverse effects of agitation are well-known, their impact on morbidity, mortality, length of stay, and cost are only beginning to be addressed. Meeting these challenges requires an understanding of the potential adverse effects of agitation, its causes and contributing factors, the advantages and limitations of available pharmacologic agents, and the role of nonpharmacologic interventions. This article reviews each of these issues, with a focus on clinical applications and strategies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8680497

Source DB:  PubMed          Journal:  Am J Crit Care        ISSN: 1062-3264            Impact factor:   2.228


  4 in total

Review 1.  Comparative tolerability of sedative agents in head-injured adults.

Authors:  Susan C Urwin; David K Menon
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  Agitation onset, frequency, and associated temporal factors in critically ill adults.

Authors:  Ruth S Burk; Mary Jo Grap; Cindy L Munro; Christine M Schubert; Curtis N Sessler
Journal:  Am J Crit Care       Date:  2014-07       Impact factor: 2.228

Review 3.  Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients.

Authors:  B K Wagner; D A O'Hara
Journal:  Clin Pharmacokinet       Date:  1997-12       Impact factor: 6.447

4.  Dexmedetomidine versus midazolam for conscious sedation in endoscopic retrograde cholangiopancreatography: An open-label randomised controlled trial.

Authors:  Priyanka Sethi; Sadik Mohammed; Pradeep Kumar Bhatia; Neeraj Gupta
Journal:  Indian J Anaesth       Date:  2014-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.